Lifibrol

Lifibrol is a potent and oral activity hypolipidemic agent. Lifibrol decreases the plasma total cholesterol. Lifibrol has the potential for the research of hypercholesterolemia[1][2].

Product Specifications

CAS Number

[96609-16-4]

UNSPSC

12352005

Target

Others

Type

Reference compound

Related Pathways

Others

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/lifibrol.html

Solubility

10 mM in DMSO

Smiles

O=C(C1=CC=C(C=C1)OCC(CCC2=CC=C(C=C2)C(C)(C)C)O)O

Molecular Formula

C21H26O4

Molecular Weight

342.43

References & Citations

[1]Locker PK, et al. Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group. Clin Pharmacol Ther. 1995 Jan;57 (1) :73-88. |[2]Bell FP, et al. Action of the new hypolipidemic agent lifibrol (K12.148) on lipid homeostasis in normal rats: plasma lipids, hepatic sterologenesis, and the fate of injected [14C]acetate. Lipids. 1993 Dec;28 (12) :1079-85.